"Excellent finish to the year with strong growth and high profitability" Fourth quarter and full year summary October - December Total revenues grew 48% (44% at CER1) to SEK 553 (375) million Sales ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...